A Review of Biomarkers and Their Clinical Impact in Resected Early-Stage Non-Small-Cell Lung Cancer

A Review of Biomarkers and Their Clinical Impact in Resected Early-Stage Non-Small-Cell Lung Cancer

The postoperative survival of early-stage non-small-cell lung cancer (NSCLC) patients remains unsatisfactory. In this review, we examined the relevant literature to ascertain the prognostic effect of related indicators on early-stage NSCLC. The prognostic effects of the epidermal growth factor recep...

Full description

Bibliographic Details
Main Authors: Weibo Cao, Quanying Tang, Jingtong Zeng, Xin Jin, Lingling Zu, Song Xu
Format: Article
Language:English
Published: MDPI AG 2023-09-01
Series:Cancers
Subjects:
non-small-cell lung cancer
early-stage
surgery
biomarkers
prognosis
Online Access:https://www.mdpi.com/2072-6694/15/18/4561

Similar Items

Similar Items